Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Neuronal cell types, projections, and spatial organization of the central amygdala.

Autor: O'Leary TP; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada., Kendrick RM; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada., Bristow BN; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada., Sullivan KE; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada., Wang L; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA., Clements J; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA., Lemire AL; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA., Cembrowski MS; Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada.; Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada.; School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.

Publikováno v: IScience [iScience] 2022 Nov 04; Vol. 25 (12), pp. 105497. Date of Electronic Publication: 2022 Nov 04 (Print Publication: 2022).

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.

Autor: Ennishi D; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan., Healy S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Bashashati A; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada., Saberi S; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada., Hother C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Mottok A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany., Chan FC; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Bioinformatics Graduate Program, University of British Columbia, Vancouver, British Columbia, Canada., Chong L; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Abraham L; Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada., Kridel R; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Boyle M; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Meissner B; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Aoki T; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Takata K; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Woolcock BW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Viganò E; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Gold M; Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada., Molday LL; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada., Molday RS; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada., Telenius A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Li MY; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Wretham N; Department of Experimental Therapeutics, British Columbia Cancer, Vancouver, British Columbia, Canada., Dos Santos N; Department of Experimental Therapeutics, British Columbia Cancer, Vancouver, British Columbia, Canada., Wong M; Trillium Therapeutics Inc., Mississauga, Ontario, Canada., Viller NN; Trillium Therapeutics Inc., Mississauga, Ontario, Canada., Uger RA; Trillium Therapeutics Inc., Mississauga, Ontario, Canada., Duns G; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Baticados A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Madero A; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Bristow BN; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Farinha P; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Slack GW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Ben-Neriah S; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Lai D; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada., Zhang AW; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada., Salehi S; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada., Shulha HP; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Chiu DS; Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada., Mostafavi S; Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada., Gerrie AS; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Huang DW; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rushton C; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada., Villa D; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Sehn LH; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Savage KJ; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Mungall AJ; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Weng AP; Terry Fox Laboratory, British Columbia Cancer, Vancouver, British Columbia, Canada., Bally MB; Department of Experimental Therapeutics, British Columbia Cancer, Vancouver, British Columbia, Canada., Morin RD; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Cohen Freue GV; Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada., Staudt LM; Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Connors JM; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada., Marra MA; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer, Vancouver, British Columbia, Canada., Shah SP; Molecular Oncology, British Columbia Cancer, Vancouver, British Columbia, Canada.; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Gascoyne RD; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Scott DW; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada. dscott8@bccancer.bc.ca., Steidl C; Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, British Columbia, Canada. CSteidl@bccancer.bc.ca.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. CSteidl@bccancer.bc.ca.

Publikováno v: Nature medicine [Nat Med] 2020 Apr; Vol. 26 (4), pp. 577-588. Date of Electronic Publication: 2020 Feb 24.

Risk factors for severe malaria among hospitalized patients in the United States, 2000-2014.

Autor: Khuu D; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA. Electronic address: dkhuu@ucla.edu., Eberhard ML; Centers for Disease Control and Prevention, Center for Global Health, Division of Parasitic Diseases & Malaria, Parasitic Diseases Branch, 1600 Clifton Road Atlanta, GA 30329-4027, USA. Electronic address: mle1@cdc.gov., Bristow BN; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA. Electronic address: benbristowmd@gmail.com., Javanbakht M; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA. Electronic address: javan@ucla.edu., Ash LR; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA. Electronic address: larryash@ucla.edu., Shafir SC; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA. Electronic address: sshafir@ucla.edu., Sorvillo FJ; Department of Epidemiology, University of California at Los Angeles, Fielding School of Public Health, 650 Charles Young Drive South, Box 951772, Los Angeles, CA 90095, USA.

Publikováno v: Infection, disease & health [Infect Dis Health] 2018 Jun; Vol. 23 (2), pp. 93-106. Date of Electronic Publication: 2018 Feb 14.

Melanoma-related mortality and productivity losses in the USA, 1990-2008.

Autor: Bristow BN; Preventive Medicine Residency Program, California Department of Public Health, Sacramento, California, USA., Casil J, Sorvillo F, Basurto-Dávila R, Kuo T

Publikováno v: Melanoma research [Melanoma Res] 2013 Aug; Vol. 23 (4), pp. 331-5.